Diminution of the T8 subset by amiprilose hydrochloride in refractory RA.
D000276:Adjuvants, Immunologic / Q000009:adverse effects / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000097:blood / Q000188:drug therapy*; D005260:Female; D005944:Glucosamine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D012266:Ribose / Q000031:analogs & derivatives; D013601:T-Lymphocytes / Q000187:drug effects*
D000276:Adjuvants, Immunologic; D012266:Ribose; D005944:Glucosamine; C018424:amiprilose